Novel iatrogenic amyloidosis caused by peptide drug liraglutide: a clinical mimic of AL amyloidosis

Amyloidoses are a group of heterogeneous diseases caused by the extracellular deposition of insoluble proteins or peptides in a beta-pleated sheet pattern.[1][1]–[4][2] There are approximately 30 different proteins that are known to produce the disease in humans.[5][3] In addition, iatrogenic